Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
54
NCT01772056
Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 31, 2009
Completion: Mar 31, 2013